V5Z.F Sirnaomics Ltd.

Healthcare Biotechnology Frankfurt Exchange
0.4420 EUR
Close of Nov 12, 2026
0.3860 1.07
Market cap
EUR 49.2M
P/E
-
P/B
0.84x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is V5Z.F undervalued?

Graham number

The Graham number of Sirnaomics Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sirnaomics Ltd. fundamental analysis

No fundamental analysis for Sirnaomics Ltd. yet.

Sirnaomics Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sirnaomics Ltd.

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs in the People's Republic of China. The company's therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates comprising STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; STP369 t…

Full company profile